REG1 beta Polyclonal Antibody

Immunohistochemistry Human - REG1

Experiment
Immunohistochemistry Human - REG1
Product
REG1 beta Polyclonal Antibody from Bioss
Manufacturer
Bioss

Protocol tips

Publication protocol

Specimens obtained during surgery were quickly fixed in 10% neutral-buffered formalin, dehydrated, and embedded in paraffin using standard techniques. Paraffin-embedded samples were serially sectioned at 4 μm, mounted on adhesion microscope slides, and baked at 60 °C for 1 h. After paraffin sections were deparaffinized in xylene and hydrated through a graded series of alcohol, they were treated in 10 mM (pH 6.0) citrate buffer for 5 min by autoclaving to retrieve antigenicity, cooled to room temperature, blocked with 3% H2O2 for 10 min, and rinsed 3 times for 3 min in phosphate-buffered saline (PBS, pH 7.2–7.4). The sections were then incubated with 10% normal goat serum in PBS to block nonspecific protein binding, followed by incubation with rabbit anti-human IgG polyclonal anti-Reg IV (Bioss, Beijing, China) at a 1:300 dilution at 37 °C for 2.5 h, and washed with PBS. The Reg IV signals were amplified and visualized with a biotinylated secondary antibody at 37 °C for 20 min and a horseradish peroxidase polymer conjugate at 37 °C for 15 min following the protocol in SP-9000 Histostain™ Plus Kits (ZYMED, South San Francisco, CA, USA). Finally, sections were stained for 5–10 min with 3–3′-Diaminobenzidine (DAB) and counterstained with 0.1% hematoxylin for nuclear staining. A negative control was set simultaneously by replacing the primary antibody with PBS. Two independent investigators analyzed samples, and differences in scoring were discussed until consensus was reached. For evaluating Reg IV expression in the various samples, a scoring criterion was taken from Sinicrope et al. [25]. For tumors that showed heterogeneous staining, the predominant pattern was taken into account for scoring. A mean percentage of positive tumor cells was determined in at least 5 areas at × 100 magnification and assigned to one of the 5 following categories: (a) 0, < 5%; (b) 1, 5–25%; (c) 2, 25–50%; (d) 3, 50–75%; and (e) 4, > 75%. The intensity of Reg IV immunostaining was scored as follows: (a) weak, 1+; (b) moderate, 2+; and (c) intense, 3+. The percentage of positive tumor cells and the staining intensity were multiplied to produce a weighted score for each case. Cases with weighted scores of less than 3 were defined as negative; otherwise they were defined as positive. Cytoplasm staining was defined as a positive expression for Reg IV. For SOX9 (1:300, Bioss) staining, the procedure used was as described above. Only nuclear immunoreactivity was considered as a positive expression.

Full paper   Login or join for free to view the full paper.

Reviews

REG1 beta Polyclonal Antibody from Bioss has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Immunohistochemistry Human - REG1 using REG1 beta Polyclonal Antibody from Bioss.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Bioss for REG1 beta Polyclonal Antibody below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Immunohistochemistry Human - REG1 using REG1 beta Polyclonal Antibody from Bioss. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms